Gastrin Hormone Market Analysis

  • Report ID: 4036
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Gastrin Hormone Market Analysis

The global gastrin hormone market is segmented and analyzed for demand and supply by salt type into segmented into ammonium acetate, trifluoroacetate, and others. Out of the three types of salt, the ammonium acetate segment is estimated to gain the largest market share of about 45% in the year 2036. The main use of ammonium acetate is in the form of a food acidity regulator. It is used in the form of a food acidity regulator. In other words, ammonium acetate is a food additive that is useful for changing and controlling the alkalinity or acidity of foods. Thus, the rising cases of acidity are expected to create favorable opportunities for segment expansion in the upcoming years. A recent report published in 2022 stated that about 30% of Indian adults suffer from acidity and indigestion problems. In addition, ammonium acetate improves the production of gastrin hormone that aids the digestion of food and is beneficial in treating gastrointestinal diseases. These factors are projected to maintain the growth of the segment during the assessment period.

The global gastrin hormone market is also segmented and analyzed for demand and supply by end-user into hospitals, specialty clinics, and others. Amongst these segments, the hospital segment is expected to garner a significant share of around 46% in the year 2036. The major factor for segment growth during the forecast period is the increasing patient footfall in hospitals owing to the rising cases of obesity, ulcers, and infections related to the stomach and gut. A report published in 2020 stated that 1 in 3 adults was overweight and 2 in 5 adults have obesity which is equivalent to 13% of adults being obese and 39% of people being overweight across the globe. Moreover, the availability of better medication and the presence of trained gastroenterologists in the hospitals are also considered to positively contribute to segment growth.

Our in-depth analysis of the global market includes the following segments:

        By Salt Type

  • Ammonium Acetate
  • Trifluoroacetate
  • Others

        By Packaging Size

  • 0.5 mg
  • 1 mg
  • 5 mg
  • Others

        By End User

  • Hospital
  • Specialty Clinics
  • Others
 
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4036
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of gastrin hormone is estimated at USD 863.37 Million.

The gastrin hormone market size was valued at USD 824.77 Million in 2023 and is projected to cross USD 1.59 Billion by the end of 2036, registering more than 5.2% CAGR during the forecast period i.e., between 2024-2036. Increasing prevalence of gastric diseases, such as gastritis, is estimated to boost the market growth.

North America industry is anticipated to have the highest growth through 2036, impelled by better reimbursement policies along with growing healthcare expenditure in the region.

Merck KGaA, RayBiotech Life, Inc., KareBay Biochem, Inc., Cayman Chemical Company, Cambridge Bioscience Limited, CPC Scientific Inc., Abcepta, GenScript Biotech Corporation, Qingdao Echemi Technology Co., Ltd., VWR International, LLC
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying